Aclaris Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Update on Clinical and Commercial Developments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. AWK
9. ACN
10. USO

Go back to Aclaris Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Update on Clinical and Commercial Developments
(NASDAQ: ACRS) Delayed: 4.92 +0.08 (1.65%)
Previous Close $4.84    52 Week High $33.88 
Open $4.77    52 Week Low $14.12 
Day High $5.12    P/E N/A 
Day Low $4.77    EPS $0.00 
Volume 1,865,406